Conference Paper: Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion

File Download
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleProfiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
AuthorsFung, JYY
Lai, CL
Tanaka, Y
Mizokami, M
Yuen, JCH
Wong, DKH
Yuen, RMF
Issue Date2007
CitationThe 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA, p. 989A [How to Cite?]
DC Field
Value
dc.contributor.authorFung, JYY
dc.contributor.authorLai, CL
dc.contributor.authorTanaka, Y
dc.contributor.authorMizokami, M
dc.contributor.authorYuen, JCH
dc.contributor.authorWong, DKH
dc.contributor.authorYuen, RMF
dc.date.accessioned2010-09-25T20:18:56Z
dc.date.available2010-09-25T20:18:56Z
dc.date.issued2007
dc.identifier.citationThe 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA, p. 989A [How to Cite?]
dc.identifier.hkuros145544
dc.identifier.spage989
dc.identifier.urihttp://hdl.handle.net/10722/102147
dc.languageeng
dc.relation.ispartofThe 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA
dc.titleProfiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
dc.typeConference_Paper